GE HealthCare
GE HealthCare Technologies Inc. (Nasdaq: GEHC) provides medical technology, pharmaceutical diagnostics, and AI-enabled, cloud and software solutions to hospitals, health systems, researchers, and public, private, academic, and government institutions. Its products and services include imaging and ultrasound equipment,… From the company’s description.
In fiscal 2025, GE HealthCare reported revenue of $20.63B, up 4.8% from fiscal 2024, and net income of $2.15B. Its operating margin was 13.4%, and operations generated $1.99B in cash. Over the twelve months to Jun 30, 2026, revenue was $21.27B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What GE HealthCare does
In the company’s own words
GE HealthCare Technologies Inc. (Nasdaq: GEHC) provides medical technology, pharmaceutical diagnostics, and AI-enabled, cloud and software solutions to hospitals, health systems, researchers, and public, private, academic, and government institutions. Its products and services include imaging and ultrasound equipment, patient monitoring and life-support systems, contrast media and radiopharmaceuticals, equipment servicing, consumables, and digital applications. The company serves customers in more than 160 countries. It reports four segments: Imaging, covering molecular imaging, CT, MR, women’s health and X-ray systems; Advanced Visualization Solutions, focused on specialized ultrasound and procedural guidance; Patient Care Solutions, offering monitoring, diagnostic cardiology, maternal-infant care, anesthesia and related digital products; and Pharmaceutical Diagnostics, supplying contrast media and radiopharmaceuticals. GE HealthCare was spun off from General Electric on January 3, 2023. It has approximately 54,000 colleagues and operates manufacturing, assembly and pharmaceutical production at 44 facilities in 17 countries.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- CHICAGO, IL
- Fiscal year end
- December
- CIK
- 1932393
- SIC
- 3844
Financial performance, year by year
Fiscal 2023–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns GE HealthCare — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in GE HealthCare · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · GE HealthCare’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
GE HealthCare’s bonds, as funds hold them
Funds report holding 9 issues of GE HealthCare’s debt, $2.36B at market value — what funds hold, not the company’s total debt. Weighted-average coupon 5.43%, maturing 2027 to 2052.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do GE HealthCare and its peers compare on margins and cash generation over ten years?”
- “Where did five years of GE HealthCare's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in GE HealthCare's last four quarterly filings that the numbers alone won't show?”